These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 24582309
1. Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype. Chan EC, Bai Y, Kirshenbaum AS, Fischer ER, Simakova O, Bandara G, Scott LM, Wisch LB, Cantave D, Carter MC, Lewis JC, Noel P, Maric I, Gilfillan AM, Metcalfe DD, Wilson TM. J Allergy Clin Immunol; 2014 Jul; 134(1):178-87. PubMed ID: 24582309 [Abstract] [Full Text] [Related]
8. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Akin C, Fumo G, Yavuz AS, Lipsky PE, Neckers L, Metcalfe DD. Blood; 2004 Apr 15; 103(8):3222-5. PubMed ID: 15070706 [Abstract] [Full Text] [Related]
9. Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis. Grootens J, Ungerstedt JS, Ekoff M, Rönnberg E, Klimkowska M, Amini RM, Arock M, Söderlund S, Mattsson M, Nilsson G, Dahlin JS. EBioMedicine; 2019 May 15; 43():150-158. PubMed ID: 30975542 [Abstract] [Full Text] [Related]
10. A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses. Smrž D, Bandara G, Zhang S, Mock BA, Beaven MA, Metcalfe DD, Gilfillan AM. J Immunol Methods; 2013 Apr 30; 390(1-2):52-62. PubMed ID: 23357051 [Abstract] [Full Text] [Related]
11. Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosis. Hoermann G, Cerny-Reiterer S, Perné A, Klauser M, Hoetzenecker K, Klein K, Müllauer L, Gröger M, Nijman SM, Klepetko W, Valent P, Mayerhofer M. Am J Pathol; 2011 May 30; 178(5):2344-56. PubMed ID: 21457934 [Abstract] [Full Text] [Related]
12. The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis. Schneeweiss M, Peter B, Bibi S, Eisenwort G, Smiljkovic D, Blatt K, Jawhar M, Berger D, Stefanzl G, Herndlhofer S, Greiner G, Hoermann G, Hadzijusufovic E, Gleixner KV, Bettelheim P, Geissler K, Sperr WR, Reiter A, Arock M, Valent P. Haematologica; 2018 May 30; 103(5):799-809. PubMed ID: 29439183 [Abstract] [Full Text] [Related]
13. A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis. Carter MC, Desai A, Komarow HD, Bai Y, Clayton ST, Clark AS, Ruiz-Esteves KN, Long LM, Cantave D, Wilson TM, Scott LM, Simakova O, Jung MY, Hahn J, Maric I, Metcalfe DD. J Allergy Clin Immunol; 2018 Jan 30; 141(1):180-188.e3. PubMed ID: 28629749 [Abstract] [Full Text] [Related]
14. KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells. Chan EC, Bai Y, Bandara G, Simakova O, Brittain E, Scott L, Dyer KD, Klion AD, Maric I, Gilfillan AM, Metcalfe DD, Wilson TM. Exp Hematol; 2013 Oct 30; 41(10):870-881.e2. PubMed ID: 23743299 [Abstract] [Full Text] [Related]
15. Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens. Mayerhofer M, Gleixner KV, Hoelbl A, Florian S, Hoermann G, Aichberger KJ, Bilban M, Esterbauer H, Krauth MT, Sperr WR, Longley JB, Kralovics R, Moriggl R, Zappulla J, Liblau RS, Schwarzinger I, Sexl V, Sillaber C, Valent P. J Immunol; 2008 Apr 15; 180(8):5466-76. PubMed ID: 18390729 [Abstract] [Full Text] [Related]
16. A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection. Saleh R, Wedeh G, Herrmann H, Bibi S, Cerny-Reiterer S, Sadovnik I, Blatt K, Hadzijusufovic E, Jeanningros S, Blanc C, Legarff-Tavernier M, Chapiro E, Nguyen-Khac F, Subra F, Bonnemye P, Dubreuil P, Desplat V, Merle-Béral H, Willmann M, Rülicke T, Valent P, Arock M. Blood; 2014 Jul 03; 124(1):111-20. PubMed ID: 24677542 [Abstract] [Full Text] [Related]
17. Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications. Jara-Acevedo M, Teodosio C, Sanchez-Muñoz L, Álvarez-Twose I, Mayado A, Caldas C, Matito A, Morgado JM, Muñoz-González JI, Escribano L, Garcia-Montero AC, Orfao A. Mod Pathol; 2015 Aug 03; 28(8):1138-49. PubMed ID: 26067933 [Abstract] [Full Text] [Related]
18. Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis. Kristensen T, Broesby-Olsen S, Vestergaard H, Bindslev-Jensen C, Møller MB, Mastocytosis Centre Odense University Hospital (MastOUH). Eur J Haematol; 2012 Jul 03; 89(1):42-6. PubMed ID: 22469616 [Abstract] [Full Text] [Related]
19. CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis. Bandara G, Falduto GH, Luker A, Bai Y, Pfeiffer A, Lack J, Metcalfe DD, Olivera A. Front Immunol; 2023 Jul 03; 14():1078958. PubMed ID: 37025992 [Abstract] [Full Text] [Related]
20. KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation. Lee YN, Brandal S, Noel P, Wentzel E, Mendell JT, McDevitt MA, Kapur R, Carter M, Metcalfe DD, Takemoto CM. Blood; 2011 Mar 31; 117(13):3629-40. PubMed ID: 21273305 [Abstract] [Full Text] [Related] Page: [Next] [New Search]